BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies deals with advanced medical devices, medication, diagnostics, and digital healthcare. BioLight's portfolio includes: DiagnosTear's TeaRx, LipiCare, ViSci, OphRx, Peripherex, AEYE, Tarsier, Belkin Vision, and Sanoculis. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
4
Frequently Asked Questions
What is Market Cap of Biolight Life Sciences Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biolight Life Sciences Ltd market cap is $38.44M.
How many employess does Biolight Life Sciences Ltd has?